These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 38911497)

  • 21. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart pH-responsive polyhydralazine/bortezomib nanoparticles for remodeling tumor microenvironment and enhancing chemotherapy.
    Wang R; Xu X; Li D; Zhang W; Shi X; Xu H; Hong J; Yao S; Liu J; Wei Z; Piao Y; Zhou Z; Shen Y; Tang J
    Biomaterials; 2022 Sep; 288():121737. PubMed ID: 36031455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precise Subcellular Organelle Targeting for Boosting Endogenous-Stimuli-Mediated Tumor Therapy.
    Zhen W; An S; Wang S; Hu W; Li Y; Jiang X; Li J
    Adv Mater; 2021 Dec; 33(51):e2101572. PubMed ID: 34611949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems.
    Ahmadzadeh R; Taheri SA; Mohammadi N; Hjazi A; Menon SV; Kadhum WR; Kumar A; Shakir MN; Shayan FK; Shirinkami N
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23782. PubMed ID: 39115384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
    Zhang Y; Han X; Nie G
    Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery.
    Sun H; Li X; Liu Q; Sheng H; Zhu L
    J Drug Target; 2024 Jul; 32(6):672-706. PubMed ID: 38682299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
    Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
    Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review.
    Meng X; Shen Y; Zhao H; Lu X; Wang Z; Zhao Y
    J Nanobiotechnology; 2024 Sep; 22(1):587. PubMed ID: 39342211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
    Chen Z; Wang X; Zhao N; Chen H; Guo G
    Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smart Drug Delivery Systems in Cancer Therapy.
    Unsoy G; Gunduz U
    Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy.
    Sun W; Xie S; Liu SF; Hu X; Xing D
    Int J Nanomedicine; 2024; 19():3919-3942. PubMed ID: 38708176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.